T.J. Powles

No ORCID on file · 4 papers in corpus
letter 1994
·doi:10.1016/s0140-6736(94)92013-3
letter 1994
·doi:10.1016/s0140-6736(94)90103-1
letter 1990
The Lancet ·doi:10.1016/0140-6736(90)91555-o
article 1984
·doi:10.1016/s0140-6736(84)91872-5

222 patients with disseminated breast cancer have been randomised to receive either a combination of hormone therapies using tamoxifen, aminoglutethimide with hydrocortisone, and danazol (TAD), or tamoxifen alone. The response to the combin…